Literature DB >> 27418053

[Inflammasome and gout].

M Aringer1, C Hedrich2, A-K Tausche3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27418053     DOI： 10.1007/s00393-016-0131-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  41 in total

1.  Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

Authors:  M F McDermott; I Aksentijevich; J Galon; E M McDermott; B W Ogunkolade; M Centola; E Mansfield; M Gadina; L Karenko; T Pettersson; J McCarthy; D M Frucht; M Aringer; Y Torosyan; A M Teppo; M Wilson; H M Karaarslan; Y Wan; I Todd; G Wood; R Schlimgen; T R Kumarajeewa; S M Cooper; J P Vella; C I Amos; J Mulley; K A Quane; M G Molloy; A Ranki; R J Powell; G A Hitman; J J O'Shea; D L Kastner
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.

Authors:  Alexander So; Marc De Meulemeester; Andrey Pikhlak; A Eftal Yücel; Dominik Richard; Valda Murphy; Udayasankar Arulmani; Peter Sallstig; Naomi Schlesinger
Journal:  Arthritis Rheum       Date:  2010-10

3.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

4.  Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.

Authors:  John S Sundy; Herbert S B Baraf; Robert A Yood; N Lawrence Edwards; Sergio R Gutierrez-Urena; Edward L Treadwell; Janitzia Vázquez-Mellado; William B White; Peter E Lipsky; Zeb Horowitz; William Huang; Allan N Maroli; Royce W Waltrip; Steven A Hamburger; Michael A Becker
Journal:  JAMA       Date:  2011-08-17       Impact factor: 56.272

5.  Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load.

Authors:  Nicola Dalbeth; Meaghan E House; Gregory D Gamble; Anne Horne; Bregina Pool; Lauren Purvis; Angela Stewart; Marilyn Merriman; Murray Cadzow; Amanda Phipps-Green; Tony R Merriman
Journal:  Ann Rheum Dis       Date:  2013-01-24       Impact factor: 19.103

6.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31

7.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

8.  Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.

Authors:  Herbert S B Baraf; Michael A Becker; Sergio R Gutierrez-Urena; Edward L Treadwell; Janitzia Vazquez-Mellado; Claudia D Rehrig; Faith D Ottery; John S Sundy; Robert A Yood
Journal:  Arthritis Res Ther       Date:  2013-09-26       Impact factor: 5.156

9.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

10.  Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.

Authors:  Fernando Perez-Ruiz; John S Sundy; Jeffrey N Miner; Matthew Cravets; Chris Storgard
Journal:  Ann Rheum Dis       Date:  2016-01-07       Impact factor: 19.103
View more
  1 in total

Review 1.  [Immunology of systemic inflammatory diseases].

Authors:  M Aringer; H Schulze-Koops
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.